-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HCWx1rh8mfyhW7kiwvygCPoR5P5EK4jUrD8S+sA1uD77xlO86A6a++x0G8KiXpcr bEEDI1OrxFitjtprirFMDw== 0001104659-04-008558.txt : 20040326 0001104659-04-008558.hdr.sgml : 20040326 20040326143738 ACCESSION NUMBER: 0001104659-04-008558 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20040324 FILED AS OF DATE: 20040326 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PERRY GREGORY D CENTRAL INDEX KEY: 0001236371 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21481 FILM NUMBER: 04692497 MAIL ADDRESS: STREET 1: C/O TRANSKARYOTIC THERAPIES INC STREET 2: 700 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TRANSKARYOTIC THERAPIES INC CENTRAL INDEX KEY: 0000885259 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 043027191 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 195 ALBANY ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6173490200 4 1 a4.xml 4 X0201 4 2004-03-24 0 0000885259 TRANSKARYOTIC THERAPIES INC TKTX 0001236371 PERRY GREGORY D 700 MAIN STREET CAMBRIDGE MA 02139 0 1 0 0 VP, Finance & CEO Stock Option (right to buy) 10.62 2004-03-24 4 A 0 8959 0 A 2014-03-24 Common Stock 8959 8959 D The option becomes exercisable in three approximately equal annual installments beginning on March 24, 2005. /s/Gregory D. Perry 2004-03-25 -----END PRIVACY-ENHANCED MESSAGE-----